• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饱和脂肪酸诱导的 miR-183-5p 通过下调肝细胞 IRS-1 抑制胰岛素信号通路。

MiR-183-5p Induced by Saturated Fatty Acids Hinders Insulin Signaling by Downregulating IRS-1 in Hepatocytes.

机构信息

Department of Biochemistry, College of Medicine, Dongguk University, 123 Dongdae-ro, Gyeongju 38066, Korea.

Channelopathy Research Center, College of Medicine, Dongguk University, 32 Dongguk-ro, Ilsan Dong-gu, Goyang 10326, Korea.

出版信息

Int J Mol Sci. 2022 Mar 10;23(6):2979. doi: 10.3390/ijms23062979.

DOI:10.3390/ijms23062979
PMID:35328400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8953084/
Abstract

Excessive saturated fatty acids (SFA) uptake is known to be a primary cause of obesity, a widely acknowledged risk factor of insulin resistance and type 2 diabetes. Although specific microRNAs (miRNAs) targeting insulin signaling intermediates are dysregulated by SFA, their effects on insulin signaling and sensitivity are largely unknown. Here, we investigated the role of SFA-induced miR-183-5p in the regulation of proximal insulin signaling molecules and the development of hepatic insulin resistance. HepG2 hepatocytes treated with palmitate and the livers of high-fat diet (HFD)-fed mice exhibited impaired insulin signaling resulting from dramatic reductions in the protein expressions of insulin receptor (INSR) and insulin receptor substrate-1 (IRS-1). Differential expression analysis showed the level of miR-183-5p, which tentatively targets the 3'UTR of , was significantly elevated in palmitate-treated HepG2 hepatocytes and the livers of HFD-fed mice. Dual-luciferase analysis showed miR-183-5p bound directly to the 3'UTR of and reduced IRS-1 expression at the post-transcriptional stage. Moreover, transfection of HepG2 hepatocytes with miR-183-5p mimic significantly inhibited IRS-1 expression and hindered insulin signaling, consequently inhibiting insulin-stimulated glycogen synthesis. Collectively, this study reveals a novel mechanism whereby miR-183-5p induction by SFA impairs insulin signaling and suggests miR-183-5p plays a crucial role in the pathogenesis of hepatic insulin resistance in the background of obesity.

摘要

已知过多的饱和脂肪酸(SFA)摄取是肥胖的主要原因,而肥胖是胰岛素抵抗和 2 型糖尿病的公认危险因素。尽管特定的针对胰岛素信号转导中间物的 microRNAs(miRNAs)被 SFA 失调,但它们对胰岛素信号转导和敏感性的影响在很大程度上尚不清楚。在这里,我们研究了 SFA 诱导的 miR-183-5p 在调节胰岛素信号转导近端分子和肝胰岛素抵抗发展中的作用。用棕榈酸处理的 HepG2 肝细胞和高脂肪饮食(HFD)喂养的小鼠的肝脏表现出胰岛素信号受损,这是由于胰岛素受体(INSR)和胰岛素受体底物-1(IRS-1)的蛋白表达显着降低所致。差异表达分析显示,miR-183-5p 的水平明显升高,miR-183-5p 暂定靶向 3'UTR,在棕榈酸处理的 HepG2 肝细胞和 HFD 喂养的小鼠的肝脏中显着升高。双荧光素酶分析显示,miR-183-5p 直接与 3'UTR 结合,并在转录后阶段降低 IRS-1 表达。此外,用 miR-183-5p 模拟物转染 HepG2 肝细胞可显着抑制 IRS-1 表达并阻碍胰岛素信号转导,从而抑制胰岛素刺激的糖原合成。总之,这项研究揭示了 SFA 诱导的 miR-183-5p 损害胰岛素信号转导的新机制,并表明 miR-183-5p 在肥胖背景下肝胰岛素抵抗的发病机制中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b17/8953084/279c3e44d1e8/ijms-23-02979-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b17/8953084/2b5454840c8e/ijms-23-02979-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b17/8953084/79657cb7cb74/ijms-23-02979-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b17/8953084/cd395e11965d/ijms-23-02979-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b17/8953084/f671007b0801/ijms-23-02979-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b17/8953084/279c3e44d1e8/ijms-23-02979-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b17/8953084/2b5454840c8e/ijms-23-02979-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b17/8953084/79657cb7cb74/ijms-23-02979-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b17/8953084/cd395e11965d/ijms-23-02979-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b17/8953084/f671007b0801/ijms-23-02979-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b17/8953084/279c3e44d1e8/ijms-23-02979-g005.jpg

相似文献

1
MiR-183-5p Induced by Saturated Fatty Acids Hinders Insulin Signaling by Downregulating IRS-1 in Hepatocytes.饱和脂肪酸诱导的 miR-183-5p 通过下调肝细胞 IRS-1 抑制胰岛素信号通路。
Int J Mol Sci. 2022 Mar 10;23(6):2979. doi: 10.3390/ijms23062979.
2
Saturated fatty acids-induced miR-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes.饱和脂肪酸诱导的 miR-424-5p 通过靶向肝细胞中的胰岛素受体加重胰岛素抵抗。
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1587-1593. doi: 10.1016/j.bbrc.2018.07.084. Epub 2018 Jul 20.
3
Induction of miR-96 by Dietary Saturated Fatty Acids Exacerbates Hepatic Insulin Resistance through the Suppression of INSR and IRS-1.膳食饱和脂肪酸诱导miR-96通过抑制胰岛素受体(INSR)和胰岛素受体底物-1(IRS-1)加重肝脏胰岛素抵抗。
PLoS One. 2016 Dec 30;11(12):e0169039. doi: 10.1371/journal.pone.0169039. eCollection 2016.
4
MiR-1271 upregulated by saturated fatty acid palmitate provokes impaired insulin signaling by repressing INSR and IRS-1 expression in HepG2 cells.饱和脂肪酸棕榈酸酯上调的MiR-1271通过抑制HepG2细胞中INSR和IRS-1的表达引发胰岛素信号传导受损。
Biochem Biophys Res Commun. 2016 Sep 30;478(4):1786-91. doi: 10.1016/j.bbrc.2016.09.029. Epub 2016 Sep 7.
5
Obesity-induced miR-15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes.肥胖诱导产生的miR-15b通过抑制肝细胞中的胰岛素受体,与胰岛素抵抗的发生存在因果关系。
Mol Nutr Food Res. 2015 Nov;59(11):2303-14. doi: 10.1002/mnfr.201500107. Epub 2015 Aug 12.
6
Saturated fatty acid-induced miR-195 impairs insulin signaling and glycogen metabolism in HepG2 cells.饱和脂肪酸诱导的miR-195损害HepG2细胞中的胰岛素信号传导和糖原代谢。
FEBS Lett. 2014 Nov 3;588(21):3939-46. doi: 10.1016/j.febslet.2014.09.006. Epub 2014 Sep 19.
7
Induction of miR-29a by saturated fatty acids impairs insulin signaling and glucose uptake through translational repression of IRS-1 in myocytes.饱和脂肪酸诱导 miR-29a 的表达,通过抑制肌细胞 IRS-1 的翻译从而损害胰岛素信号转导和葡萄糖摄取。
FEBS Lett. 2014 Jun 13;588(13):2170-6. doi: 10.1016/j.febslet.2014.05.011. Epub 2014 May 17.
8
The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes.在肝细胞线粒体功能障碍的情况下,靶向 IRS-1 的 microRNA 的诱导参与了胰岛素抵抗的发展。
PLoS One. 2011 Mar 25;6(3):e17343. doi: 10.1371/journal.pone.0017343.
9
Upregulation of miR-497 induces hepatic insulin resistance in E3 rats with HFD-MetS by targeting insulin receptor.通过靶向胰岛素受体,miR-497的上调在高脂饮食诱导的代谢综合征E3大鼠中诱发肝脏胰岛素抵抗。
Mol Cell Endocrinol. 2015 Nov 15;416:57-69. doi: 10.1016/j.mce.2015.08.021. Epub 2015 Aug 20.
10
Identification of microRNA that represses IRS-1 expression in liver.在肝脏中抑制胰岛素受体底物-1(IRS-1)表达的微小RNA的鉴定。
PLoS One. 2018 Jan 24;13(1):e0191553. doi: 10.1371/journal.pone.0191553. eCollection 2018.

引用本文的文献

1
Advance in molecular mechanisms underlying diabetes related to viral hepatitis infection.与病毒性肝炎感染相关的糖尿病分子机制研究进展
Front Cell Infect Microbiol. 2025 Aug 22;15:1661155. doi: 10.3389/fcimb.2025.1661155. eCollection 2025.
2
Involvement of miRNAs in the Cluster of Metabolic Factors of MetS: Nutrition-Genome-MetS Axis.微小RNA在代谢综合征代谢因子簇中的作用:营养-基因组-代谢综合征轴
J Clin Med. 2025 Jun 14;14(12):4234. doi: 10.3390/jcm14124234.
3
The predictive value of miR-28-5p and miR-424-5p in metabolic syndrome and their mechanism of action through regulation of Fras-1-related extracellular matrix protein 2.

本文引用的文献

1
Insulin action at a molecular level - 100 years of progress.胰岛素在分子水平上的作用——100 年的进展。
Mol Metab. 2021 Oct;52:101304. doi: 10.1016/j.molmet.2021.101304. Epub 2021 Jul 15.
2
Obesity-induced upregulation of microRNA-183-5p promotes hepatic triglyceride accumulation by targeting the B-cell translocation gene 1.肥胖诱导的 microRNA-183-5p 上调通过靶向 B 细胞易位基因 1 促进肝甘油三酯积累。
Life Sci. 2021 Mar 1;268:119011. doi: 10.1016/j.lfs.2020.119011. Epub 2021 Jan 7.
3
Metabolic Inflammation and Insulin Resistance in Obesity.
miR-28-5p和miR-424-5p在代谢综合征中的预测价值及其通过调控Fras-1相关细胞外基质蛋白2的作用机制。
Endocr J. 2025 Jul 1;72(7):831-838. doi: 10.1507/endocrj.EJ24-0539. Epub 2025 Apr 19.
4
Mechanistic insight into the role of cardiac-enriched microRNAs in diabetic heart injury.对心脏富集微小RNA在糖尿病性心脏损伤中作用的机制性洞察。
Am J Physiol Heart Circ Physiol. 2025 Apr 1;328(4):H865-H884. doi: 10.1152/ajpheart.00736.2024. Epub 2025 Mar 4.
5
The predictive function of miR-122-5p and its action mechanism by regulating PKM2 in metabolic syndrome.miR-122-5p在代谢综合征中的预测功能及其通过调控PKM2的作用机制。
BMC Endocr Disord. 2025 Feb 27;25(1):54. doi: 10.1186/s12902-025-01888-2.
6
MicroRNA, Insulin Resistance, and Metabolic Disorders.微小 RNA、胰岛素抵抗和代谢紊乱。
Int J Mol Sci. 2022 Dec 19;23(24):16215. doi: 10.3390/ijms232416215.
7
Potential role of microRNAs in selective hepatic insulin resistance: From paradox to the paradigm.微小 RNA 在选择性肝胰岛素抵抗中的潜在作用:从悖论到范例。
Front Endocrinol (Lausanne). 2022 Nov 21;13:1028846. doi: 10.3389/fendo.2022.1028846. eCollection 2022.
8
Long Non-coding RNA SPAG5-AS1 Attenuates Diabetic Retinal Vascular Dysfunction by Inhibiting Human Retinal Microvascular Endothelial Cell Proliferation, Migration, and Tube Formation by Regulating the MicroRNA-1224-5p/IRS-1 Axis.长链非编码 RNA SPAG5-AS1 通过调控 microRNA-1224-5p/IRS-1 轴抑制人视网膜微血管内皮细胞增殖、迁移和管腔形成来减轻糖尿病视网膜血管功能障碍。
Mol Biotechnol. 2023 Jun;65(6):904-912. doi: 10.1007/s12033-022-00572-3. Epub 2022 Nov 8.
肥胖相关的代谢炎症与胰岛素抵抗
Circ Res. 2020 May 22;126(11):1549-1564. doi: 10.1161/CIRCRESAHA.119.315896. Epub 2020 May 21.
4
The clinical potential of circulating microRNAs in obesity.循环 microRNAs 在肥胖症中的临床潜力。
Nat Rev Endocrinol. 2019 Dec;15(12):731-743. doi: 10.1038/s41574-019-0260-0. Epub 2019 Oct 14.
5
Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis.针对代谢、胰岛素抵抗和糖尿病治疗非酒精性脂肪性肝炎。
Diabetes. 2018 Dec;67(12):2485-2493. doi: 10.2337/dbi18-0024.
6
Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human.循环肝脏特异性 microRNAs 作为人类肝脏疾病的非侵入性诊断生物标志物。
Biomarkers. 2019 Mar;24(2):103-109. doi: 10.1080/1354750X.2018.1528631. Epub 2018 Oct 23.
7
Saturated fatty acids-induced miR-424-5p aggravates insulin resistance via targeting insulin receptor in hepatocytes.饱和脂肪酸诱导的 miR-424-5p 通过靶向肝细胞中的胰岛素受体加重胰岛素抵抗。
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1587-1593. doi: 10.1016/j.bbrc.2018.07.084. Epub 2018 Jul 20.
8
Identification of microRNA that represses IRS-1 expression in liver.在肝脏中抑制胰岛素受体底物-1(IRS-1)表达的微小RNA的鉴定。
PLoS One. 2018 Jan 24;13(1):e0191553. doi: 10.1371/journal.pone.0191553. eCollection 2018.
9
Divergent Roles of IRS (Insulin Receptor Substrate) 1 and 2 in Liver and Skeletal Muscle.胰岛素受体底物1和2在肝脏和骨骼肌中的不同作用
Curr Med Chem. 2017;24(17):1827-1852. doi: 10.2174/0929867324666170426142826.
10
Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle.2 型糖尿病中 miR-29 表达的改变影响骨骼肌中的糖和脂代谢。
Diabetes. 2017 Jul;66(7):1807-1818. doi: 10.2337/db17-0141. Epub 2017 Apr 12.